2-acetylaminofluorene has been researched along with Central Hypothyroidism in 1 studies
2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CANTAROW, A | 1 |
| WILLIAMS, TL | 1 |
| MELNICK, I | 1 |
| PASCHKIS, KE | 1 |
1 other study available for 2-acetylaminofluorene and Central Hypothyroidism
| Article | Year |
|---|---|
Influence of acetylaminofluorene, growth hormone, testosterone, and hypothyroidism on incorporation of uracil-2-C14 in liver RNA in the rat.
Topics: 2-Acetylaminofluorene; Animals; Fluorenes; Growth Hormone; Hypothyroidism; Liver; Rats; RNA; Testost | 1958 |